Biotech8 months ago
Laminar Pharma, Looking for Buyers in Europe for its New Anti-Tumor Drug
Laminar Pharma, founded by Professor Pablo Vicente Escribá, seeks to raise €7 million for its drug trial, LAM561, targeting glioblastoma. With phase III trials underway in...